Indomethacin-associated peptic ulceration.

Area of Science:

• Gastroenterology
• Pharmacology
• Internal Medicine

Background:

• Peptic ulceration is a common gastrointestinal condition.
• Non-steroidal anti-inflammatory drugs (NSAIDs) like indomethacin are frequently associated with peptic ulcer disease.
• Understanding drug-associated ulcer characteristics is vital for patient management.

Purpose of the Study:

• To review and characterize peptic ulceration associated with indomethacin therapy.
• To compare the clinical features of indomethacin-associated ulcers with non-drug-associated ulcers.

Main Methods:

• Retrospective review of hospital case notes.
• Analysis of 32 patients with indomethacin-associated peptic ulceration over a four-year period.
• Comparison with a cohort of non-drug-associated ulcer cases.

Main Results:

• Indomethacin-associated ulcers predominantly affected elderly women, unlike non-drug ulcers (males, younger age).
• Higher rates of complications (haematemesis, melaena) were observed in the indomethacin group (two-thirds vs. one-quarter).
• Relative hypochlorhydria was frequently noted during gastroscopy in indomethacin-associated ulcer patients.

Conclusions:

• Indomethacin therapy poses a significant risk for peptic ulceration, particularly in elderly women.
• Patients on prolonged indomethacin require regular monitoring for dyspepsia and anemia.
• Diagnostic procedures like barium meals or gastroscopy are indicated for even mild symptoms in these patients.